Press Releases

Sep 21, 2022 Press Release
Washington, D.C. (September 21, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for a hearing on “Examining Long-Term Care in America: The Impact of the Coronavirus in Nursing Homes” with nursing home experts, a frontline worker, and a resident advocate.
Sep 16, 2022 Press Release
Over 200,000 residents and staff in long-term care facilities have died from the coronavirus since the start of the pandemic
Washington, D.C. (September 16, 2022) – On Wednesday, September 21, 2022, at 2:00 p.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid hearing on the impact of the coronavirus in our nation’s nursing homes. Witnesses will include nursing home experts, an advocate, and a frontline worker who will testify to the challenges that the coronavirus pandemic has posed to nursing home residents and staff and what measures can be adopted to ensure nursing homes are better equipped to protect residents and staff in the future.
Sep 9, 2022 Press Release
Contrary to intent of relief programs, airlines cut their workforce through buyouts and retirement packages, worsening pilot shortage and flight delays
Washington, D.C. (Sept. 9, 2022) — Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, sent a letter to Mr. Richard K. Delmar, Deputy Inspector General of the Department of the Treasury, requesting a thorough review of the federal funding Treasury disbursed to airlines to sustain their operations during the coronavirus pandemic, including whether any funds were used for buyouts or staff reductions.
Aug 31, 2022 Press Release
Washington, D.C. (August 31, 2022) – Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement after the Food and Drug Administration’s (FDA) authorized Moderna and Pfizer-BioNTech single dose bivalent coronavirus vaccines for use as a booster at least two months following primary or booster vaccination.
Aug 24, 2022 Press Release
Report is the second to reveal Select Subcommittee’s findings from its investigation into the Trump Administration’s political interference with the federal coronavirus response
Washington, D.C. (August 24, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a staff report revealing extensive new evidence of the Trump White House’s relentless pressure campaigns targeting the Food and Drug Administration’s (FDA) coronavirus response. This staff report is the second installment in a series of reports documenting the Select Subcommittee’s findings from its investigation into the Trump Administration’s rampant political interference with the federal public health response to the coronavirus pandemic.
Aug 11, 2022 Press Release
Newly rejected vaccines bring total number of Emergent’s wasted doses to 525 million
Washington, D.C. (August 11, 2022)—Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, and Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, released new evidence that 135 million coronavirus vaccine doses manufactured at Emergent BioSolutions’ Bayview facility in Baltimore, Maryland between August 2021 and February 2022 were designated for destruction following the discovery of quality deficiencies.
Jul 28, 2022 Press Release
Clyburn refers two companies for further investigation
Washington, D.C. (July 28, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, released a new staff report with findings from its year-long investigation into the eviction practices of four large corporate landlords during the first 16 months of the coronavirus pandemic.
Jul 19, 2022 Press Release
Experts and impacted Americans urge further action to address challenges facing millions of Americans with the condition
Washington, D.C. (July 19, 2022) – Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing on Long COVID and its public health and economic consequences, examining how employers and governments at all levels can collaborate to invest in research, provide high-quality care, and address the condition’s negative impacts on the American economy and health care system.
Jul 19, 2022 Press Release
Washington, D.C. (July 19, 2022) – Below is Select Subcommittee on the Coronavirus Crisis Chairman James E. Clyburn’s opening statement, as delivered, for a hearing on “Understanding and Addressing Long COVID and Its Consequences” with experts in public health and the workforce, a patient advocate, and an impacted American.
Jul 18, 2022 Press Release
Estimated 1 million Americans have been forced to leave the labor market due to health consequences of Long COVID
Washington, D.C. (July 18, 2022) – Tomorrow, July 19, 2022, at 10:00 a.m. ET, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid hearing on understanding and addressing Long COVID and its consequences. A public health expert, an expert in economics and workforce issues, a patient advocate, and an impacted American will testify to the impacts of Long COVID, and how the federal government can help Americans managing Long COVID as the nation continues to move beyond the coronavirus crisis.

Pages